Cargando…
Deprescribing process in demented patients: What is the rationale?
Polypharmacy is rather a rule than an exemption in the elderly. This applies also to the demented population, whether they live in private homes or in nursing homes. The application of multiple drugs increases the risk to develop delirium, to promote falling and to hasten cognitive decline, What can...
Autor principal: | Stoppe, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471250/ http://dx.doi.org/10.1192/j.eurpsy.2021.184 |
Ejemplares similares
-
Clinical aspects of deprescribing process in affective disorders
por: Bouckaert, F.
Publicado: (2021) -
DEPRESCRIBING IN ASSISTED LIVING
por: Zarowitz, Barbara, et al.
Publicado: (2022) -
Metabolomic Profile Differences Between Demented and Non-Demented APOE4 Carriers in the Long Life Family Study
por: Jain, Mohit, et al.
Publicado: (2021) -
Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023) -
Antipsychotics for elderly with psychosis: Deprescribe or continue?
por: Mohr, P.
Publicado: (2021)